CELC Celcuity Inc.
$92.00
Celcuity Inc. (CELC) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $1.11 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +10.8% since its last earnings release on August 13, 2026.
Celcuity Missed Consensus Estimates
Thursday, August 13, 2026 · 4:06 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · 4:00 PM ET
Earnings Whisper
-
vs ($1.11)
Rev est $20.38M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$92.00
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Celcuity Inc.
Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic and companion diagnostic strategy.
Sector
Healthcare
Industry
Biotechnology